Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.

Leukemia & lymphoma - 1 May 2022

Amaador Karima, Vos Josephine M I, Pals Steven T, Kraan Willem, Dobber Johan A, Minnema Monique C, Koene Harry R, de Bruin Peter C, Zwinderman Aiko H, Kersten Marie José

Abstract excerpt

Discrimination between Waldenström macroglobulinemia (WM) and marginal zone lymphoma (MZL) of the bone marrow (BM) can be difficult due to overlap in clinical, histopathologic, and immunophenotypic characteristics. We determined which characteristics can aid in the differential diagnosis of 'gray zone' cases. We compared clinical, histopathologic, immunophenotypic, and molecular features of 222 WM and 65 MZL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma, B-Cell, Marginal Zone

Share to Mutation

Share to Myeloid Differentiation Factor 88

Share to Waldenstrom Macroglobulinemia

Source

Identifiers

PMID: 34961399
DOI: 10.1080/10428194.2021.2018584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression.PMID 34961399Read ↗

Recent updates in the indolent lymphomas: Update on marginal zone lymphoma and Waldenström's macroglobulinemia.Semantic proximity Read ↗

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?Semantic proximity Read ↗

Phenotypic Profile of Waldenström Macroglobulinaemia B-Cells: Establishment of a Diagnosis Scoring System and Clinico-Biological Correlations.Semantic proximity Read ↗

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.Semantic proximity Read ↗

New developments in the diagnosis and characterization of Waldenström's macroglobulinemia.Semantic proximity Read ↗

SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.Semantic proximity Read ↗

MYD88 wild-type Waldenstrom Macroglobulinaemia: differential diagnosis, risk of histological transformation, and overall survival.Semantic proximity Read ↗

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects.Semantic proximity Read ↗

Lymphoplasmacytic Lymphoma/Waldenstrom MacroglobulinemiaSemantic proximity Read ↗

Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis.Semantic proximity Read ↗

Survival Machine Learning Methods Improve Prediction of Histologic Transformation in Follicular and Marginal Zone LymphomasSemantic proximity Read ↗

[Therapeutic algorithm of Waldenström's macroglobulinemia or lymphoplasmacytic lymphoma in Japan].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.